Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Prednisolone acetate + sulfacetamide sodium |
Is a |
Product containing sulfacetamide (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate + sulfacetamide sodium |
Is a |
Product containing prednisolone (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate + sulfacetamide sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Corticosterone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate + sulfacetamide sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Prednisolone acetate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate + sulfacetamide sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Sulfacetamide sodium |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate + sulfacetamide sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Adrenal hormone agent |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate + sulfacetamide sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Glucocorticoid hormone |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate + sulfacetamide sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bactericide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate + sulfacetamide sodium |
Is a |
Product containing sulfacetamide in ophthalmic dosage form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate + sulfacetamide sodium |
Is a |
Prednisolone-containing product in ocular dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Prednisolone acetate + sulfacetamide sodium |
Has manufactured dose form |
Ocular dose form (dose form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|